Lithium Carbonate combined with Olanzapine

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
White Blood Cell Count Increased Hospitalization 62 Female 1/3/2006 Turkey
Primary
Secondary
Vomiting Hospitalization 11/7/2005 34 Male 1/16/2006 France
Primary
Secondary
Gastrointestinal Haemorrhage Other Serious 11/11/2003 46 Male 172 lb 1/6/2006 Lawyer United States
Primary
Concomitant
White Blood Cell Count Increased Hospitalization 62 Female 1/10/2006
Primary
Secondary
Fall Other Serious Male 1/18/2006 United Kingdom
Primary
Concomitant
Fall Disability 10/1/2005 65 Male 1/20/2006 Physician United Kingdom
Primary
Concomitant
Weight Decreased Other Serious 3/1/2005 71 Female 216 lb 1/15/2006 Physician Netherlands
Primary
Concomitant
Treatment Noncompliance Disability 10/1/2005 64 Male 1/24/2006 Other Health Professional United Kingdom
Primary
Concomitant
Thrombocytopenia Other Serious 12/23/2005 72 Female 1/20/2006 United Kingdom
Primary
Concomitant
Rash 1/30/2006 Male 158 lb 2/6/2006 Pharmacist United States
Primary
Concomitant
White Blood Cell Count Increased Other Serious 9/3/2003 46 Male 172 lb 2/2/2006 Lawyer United States
Primary
Secondary
Concomitant
Vomiting Hospitalization 11/7/2005 34 Male 2/15/2006 Consumer France
Primary
Secondary
Neuroleptic Malignant Syndrome Life Threatening 1/6/2006 23 Male 2/24/2006 Consumer United Kingdom
Primary
Secondary
Concomitant
Ventricular Hypokinesia Other Serious 5/1/2000 31 Male 3/21/2006 Physician Australia
Primary
Concomitant
Pseudomonas Infection Life Threatening 8/8/2005 45 Male 4/6/2006 Other Health Professional France
Primary
Secondary
Restlessness Hospitalization 5/1/2004 51 Male 4/5/2006 Spain
Primary
Secondary
Concomitant
Prothrombin Time Ratio Decreased Hospitalization 2/20/2006 40 Female 4/20/2006 Other Health Professional France
Primary
Secondary
Concomitant
Tremor Hospitalization 10/26/2004 46 Male 4/25/2006 United States
Primary
Concomitant
Platelet Count Decreased Required Intervention 9/1/2005 15 Male 1/31/2006 Physician United States
Primary
Secondary
Concomitant
Pneumonia Hospitalization 12/20/2005 68 Male 152 lb 1/4/2006 Other Health Professional United States
Primary
Concomitant
Staphylococcal Infection Life Threatening 2/20/2005 49 Male 6/16/2006 Other Health Professional France
Primary
Secondary
Concomitant
Therapy Non-responder Other Serious 17 Female 6/27/2006 Physician Spain
Primary
Secondary
Concomitant
Thermal Burn Other Serious 5/15/2006 65 Male 309 lb 7/10/2006 Other Health Professional United Kingdom
Primary
Concomitant
Multiple Drug Overdose Life Threatening 43 Female 6/16/2006 United States
Primary
Secondary
Concomitant
Pyrexia Hospitalization 50 Female 7/21/2006 Japan
Primary
Secondary
Concomitant
Pyrexia Hospitalization 50 Female 7/25/2006 Japan
Primary
Secondary
Concomitant
Suicide Attempt Other Serious Male 8/2/2006 Canada
Primary
Secondary
Concomitant
Therapeutic Agent Toxicity Hospitalization 4/24/2006 60 Male 219 lb 4/24/2006 Pharmacist United States
Primary
Concomitant
Neurotoxicity Other Serious 22 Female 9/1/2006 Brazil
Primary
Concomitant
Therapy Non-responder Hospitalization 22 Female 9/5/2006 Germany
Primary
Secondary
Concomitant
Oculogyration Other Serious 22 Female 8/31/2006
Primary
Secondary
Priapism 6/23/2006 Male 182 lb 9/8/2006 Pharmacist United States
Primary
Concomitant
Ventricular Fibrillation Death 53 Female 9/13/2006 Physician United States
Primary
Secondary
Vomiting Other Serious 1/1/2003 Male 140 lb 9/19/2006 Physician United States
Primary
Secondary
Concomitant
Interacting
Renal Failure Chronic Death 21 Male 9/25/2006 Consumer United Kingdom
Primary
Secondary
Concomitant
Renal Failure Chronic Other Serious 21 Male 9/25/2006 United States
Primary
Concomitant
Treatment Noncompliance Death 8/1/2006 58 Male 9/28/2006 Other Health Professional Australia
Primary
Concomitant
Psychomotor Hyperactivity Hospitalization 15 Male 10/12/2006 Consumer India
Primary
Concomitant
Self Injurious Behaviour Other Serious 5/15/2006 56 Male 10/13/2006 Consumer United Kingdom
Primary
Concomitant
Polyuria Hospitalization 33 Male 10/20/2006 Consumer Taiwan, Province Of China
Primary
Secondary
Concomitant
Mania Hospitalization 2/17/2006 56 Female 10/23/2006 Other Health Professional United States
Primary
Secondary
Concomitant
Self Injurious Behaviour Other Serious 5/15/2006 56 Male 10/24/2006 Consumer United Kingdom
Primary
Concomitant
Mania Hospitalization 2/17/2006 56 Female 10/27/2006 Other Health Professional United States
Primary
Secondary
Concomitant
Wrong Technique In Drug Usage Process Other Serious 1/1/2000 50 Male 333 lb 11/8/2006 Lawyer United States
Primary
Concomitant
Wrong Technique In Drug Usage Process Other Serious 1/1/2000 50 Male 333 lb 11/13/2006 Lawyer United States
Primary
Concomitant
Toxic Induced Encephalopathy Hospitalization 1/1/2006 Female 11/13/2006 Physician France
Primary
Concomitant
Toxic Induced Encephalopathy Hospitalization 1/1/2006 Female 11/13/2006 Physician France
Primary
Concomitant
Toxic Induced Encephalopathy Hospitalization 1/1/2006 Female 11/13/2006 Physician France
Primary
Concomitant
Toxic Induced Encephalopathy Hospitalization 1/1/2006 Female 11/13/2006 Physician France
Primary
Concomitant
Toxic Induced Encephalopathy Hospitalization 1/1/2006 Female 11/13/2006 Physician France
Primary
Concomitant
Toxic Induced Encephalopathy Hospitalization 1/1/2006 Female 11/13/2006 Physician France
Primary
Concomitant
Toxic Induced Encephalopathy Hospitalization 1/1/2006 Female 11/13/2006 Physician France
Primary
Concomitant
Wrong Technique In Drug Usage Process Other Serious 1/1/2000 50 Male 333 lb 11/16/2006 Physician United States
Primary
Concomitant
Tremor Hospitalization 7/7/2005 42 Male 181 lb 11/22/2006 Physician Australia
Primary
Concomitant
Weight Increased Other Serious 10/28/2004 51 Female 160 lb 11/17/2006 United States
Primary
Concomitant
Ventricular Fibrillation Other Serious 53 Female 11/21/2006 Physician United States
Primary
Secondary
Postictal State Hospitalization 10/11/2006 18 Female 11/22/2006 Pharmacist United States
Primary
Concomitant
Pyelonephritis Hospitalization 8/1/2006 63 Female 12/15/2006 Physician France
Primary
Concomitant
Interacting
Oculogyration Hospitalization 22 Female 12/11/2006 Physician Germany
Primary
Secondary
Concomitant
Pyelonephritis Hospitalization 8/1/2006 63 Female 12/22/2006 Physician France
Primary
Concomitant
Interacting
Oculogyration Other Serious 22 Female 1/12/2007 Physician Germany
Primary
Concomitant
Interacting
Posture Abnormal Other Serious 52 Female 1/19/2007 Other Health Professional Spain
Primary
Secondary
Encephalopathy Hospitalization 50 Female 150 lb 1/4/2007 Pharmacist United States
Primary
Secondary
Concomitant
Prescribed Overdose Other Serious 5/9/2002 24 Male 150 lb 10/10/2006 Lawyer United States
Primary
Concomitant
Posture Abnormal Other Serious 52 Female 1/25/2007 Physician Spain
Primary
Concomitant
Drug Withdrawal Syndrome Other Serious Female 2/6/2007 Physician United Kingdom
Primary
Concomitant
Pulmonary Embolism Hospitalization 50 Female 2/7/2007 Physician Spain
Primary
Concomitant
Urine Output Decreased Other Serious 1/1/2007 21 Male 2/7/2007 Consumer Australia
Primary
Concomitant
Urine Output Decreased Other Serious 1/1/2007 21 Male 2/16/2007 Consumer Australia
Primary
Concomitant
Mood Altered Other Serious Male 2/26/2007 Physician Ireland
Primary
Interacting
Thinking Abnormal Other Serious Male 2/27/2007 Physician Ireland
Primary
Interacting
Balance Disorder Hospitalization 1/1/2006 60 Female 2/23/2007 Physician Australia
Primary
Concomitant
Neutropenia Other Serious 36 Female 3/7/2007 Other Health Professional United Kingdom
Primary
Concomitant
Interacting
Mental Disorder Other Serious 4/4/2004 51 Female 198 lb 3/7/2007 Physician United States
Primary
Concomitant
Death Death 5/7/2005 56 Male 3/7/2007 Consumer Australia
Primary
Concomitant
Stevens-johnson Syndrome Hospitalization 23 Male 3/15/2007
Primary
Secondary
Febrile Neutropenia Hospitalization 3/16/2007 38 Male 4/5/2007 Physician United States
Primary
Secondary
Concomitant
Self-injurious Ideation Other Serious 1/29/2007 30 Male 154 lb 4/11/2007 Physician Ireland
Primary
Interacting
Drug Exposure During Pregnancy Congenital Anomaly Female 4/23/2007 Other Health Professional Australia
Primary
Secondary
Urine Ketone Body Present Other Serious 34 Male 4/25/2007 Other Health Professional United States
Primary
Secondary
Concomitant
Serotonin Syndrome Other Serious 41 Male 5/4/2007 Switzerland
Primary
Secondary
Concomitant
Tardive Dyskinesia Other Serious 1/1/2002 Male 187 lb 5/7/2007 Physician United States
Primary
Concomitant
Therapeutic Agent Toxicity Hospitalization 8/3/2006 50 Female 150 lb 5/8/2007 Consumer United States
Primary
Secondary
Concomitant
Overdose Other Serious 43 Female 2/5/2007 United States
Primary
Secondary
Pulmonary Embolism Hospitalization 3/21/2007 53 Male 5/25/2007 Other Health Professional France
Primary
Secondary
Toxic Encephalopathy Hospitalization 5/19/2007 62 Female 7/5/2007 Consumer United Kingdom
Primary
Secondary
Concomitant
Wheezing Other Serious 5/26/2007 37 Male 7/17/2007 Other Health Professional United Kingdom
Primary
Concomitant
White Blood Cell Count Increased Hospitalization 11/1/2005 16 Female 8/10/2007
Primary
Secondary
White Blood Cell Count Increased Hospitalization 11/1/2005 16 Female 8/20/2007 India
Primary
Concomitant
Rash Maculo-papular Hospitalization 33 Female 9/5/2007 Consumer Korea, Republic Of
Primary
Concomitant
White Blood Cell Count Decreased Hospitalization 2/1/2006 39 Male 9/11/2007 Other Health Professional United States
Primary
Concomitant
Syncope Other Serious 42 Male 10/1/2007
Primary
Concomitant
Ventricular Hypokinesia Other Serious 5/1/2000 31 Male 11/8/2007 Physician Australia
Primary
Concomitant
Tachyarrhythmia Hospitalization 9/14/2007 83 Female 11/14/2007 Physician United Kingdom
Primary
Concomitant
Tremor Other Serious 1/1/2007 50 Male 11/20/2007 Physician Germany
Primary
Concomitant
Hospitalisation Hospitalization 12/12/2006 64 Male 202 lb 11/21/2007 Physician Germany
Primary
Concomitant
Gamma-glutamyltransferase Increased Other Serious 1/27/2006 64 Female 11/26/2007 Physician Germany
Primary
Concomitant
Overdose Life Threatening 43 Female 12/11/2007 Lawyer United States
Primary
Secondary
Pleurothotonus Other Serious 39 Female 1/7/2008 France
Primary
Secondary
Interacting
Neutrophil Count Decreased Other Serious 12/9/2007 28 Male 2/25/2008 Physician United Kingdom
Primary
Secondary
Concomitant
Interacting
Insomnia Other Serious 1/15/2008 54 Female 2/29/2008 Other Health Professional United Kingdom
Primary
Concomitant
Neutrophil Count Decreased Other Serious 12/9/2007 28 Male 3/6/2008 Physician United Kingdom
Primary
Secondary
Concomitant
Interacting
Dysarthria Other Serious Female 183 lb 3/11/2008 Canada
Primary
Concomitant
Drug Interaction Other Serious Male 3/14/2008 Other Health Professional United Kingdom
Primary
Interacting
Nausea 9/26/2007 Female 135 lb 3/14/2008 United States
Primary
Concomitant
Neutrophil Count Decreased Other Serious 12/9/2007 28 Male 3/20/2008 Physician United Kingdom
Primary
Secondary
Concomitant
Interacting
Insomnia Other Serious 1/15/2008 54 Female 3/25/2008 Other Health Professional United Kingdom
Primary
Concomitant
Dysarthria Other Serious Female 183 lb 4/4/2008 Canada
Primary
Concomitant
Drug Interaction Other Serious Male 4/4/2008 Physician United Kingdom
Primary
Interacting
Neutrophil Count Decreased Other Serious 3/19/2007 Male 4/11/2008 Physician United States
Primary
Secondary
Concomitant
Drug Interaction Other Serious Male 4/4/2008 Other Health Professional United Kingdom
Primary
Secondary
Drug Interaction Other Serious Male 4/7/2008 United Kingdom
Primary
Secondary
Drug Interaction Other Serious Male 4/9/2008 Physician United Kingdom
Primary
Secondary
Drug Interaction Other Serious Female 4/11/2008 Other Health Professional United Kingdom
Primary
Concomitant
Drug Interaction Other Serious Male 4/11/2008 United Kingdom
Primary
Secondary
Urinary Incontinence Disability 1/1/2008 49 Male 4/11/2008 Physician United Kingdom
Primary
Concomitant
Tobacco Interaction Hospitalization 38 Male 4/17/2008 Spain
Primary
Secondary
Concomitant
White Blood Cell Count Increased Hospitalization 11/1/2005 16 Female 4/22/2008 Physician India
Primary
Concomitant
Therapeutic Agent Toxicity Hospitalization Male 4/29/2008 United Kingdom
Primary
Secondary
Therapeutic Agent Toxicity Hospitalization Male 4/29/2008 United Kingdom
Primary
Secondary
Unevaluable Event Other Serious 49 Female 4/30/2008 Physician Spain
Primary
Secondary
Concomitant
Therapeutic Agent Toxicity Hospitalization Male 5/14/2008 United Kingdom
Primary
Secondary
Twin Pregnancy Hospitalization Male 5/8/2008 United Kingdom
Primary
Secondary
Urinoma Hospitalization 39 Female 5/8/2008 United Kingdom
Primary
Secondary
Therapeutic Agent Toxicity Hospitalization Male 5/8/2008 United Kingdom
Primary
Secondary
Tremor Hospitalization 4/8/2008 Male 128 lb 5/16/2008 Physician Australia
Primary
Secondary
Concomitant
Therapeutic Agent Toxicity Hospitalization Male 5/20/2008 Other Health Professional United Kingdom
Primary
Secondary
Therapeutic Agent Toxicity Hospitalization Male 5/20/2008 United Kingdom
Primary
Secondary
Concomitant
Pitting Oedema Hospitalization 3/12/2008 39 Female 5/21/2008 Physician Australia
Primary
Concomitant
Therapeutic Agent Toxicity Hospitalization Male 5/15/2008 United Kingdom
Primary
Secondary
Urinoma Hospitalization 39 Female 5/15/2008 United States
Primary
Secondary
Therapeutic Agent Toxicity Hospitalization 5/27/2008 United Kingdom
Primary
Secondary
Concomitant
Antipsychotic Drug Level Increased Hospitalization 36 Female 5/28/2008 Consumer Australia
Primary
Concomitant
Interacting
Therapeutic Agent Toxicity Other Serious 39 Female 115 lb 5/28/2008 United Kingdom
Primary
Secondary
Concomitant
Pulmonary Oedema Other Serious 11 Male 6/6/2008 United States
Primary
Concomitant
Traumatic Shock Other Serious 2/4/1999 Female 6/10/2008 Lawyer United States
Primary
Concomitant
Unevaluable Event Hospitalization 3/12/2008 21 Male 6/13/2008 Physician United States
Primary
Secondary
Concomitant
Therapeutic Agent Toxicity Other Serious Male 6/16/2008 Other Health Professional United Kingdom
Primary
Secondary
Unevaluable Event Other Serious 3/12/2008 21 Male 6/19/2008 Physician United States
Primary
Secondary
Concomitant
Unevaluable Event Other Serious 3/12/2008 21 Male 6/30/2008 Physician United States
Primary
Secondary
Concomitant
Therapeutic Agent Toxicity Other Serious Male 7/8/2008 Other Health Professional United Kingdom
Primary
Secondary
Therapeutic Agent Toxicity Other Serious 1 Male 7/11/2008 Other Health Professional United Kingdom
Primary
Secondary
Therapeutic Agent Toxicity Other Serious 39 Female 7/11/2008 Other Health Professional United Kingdom
Primary
Secondary
Therapeutic Agent Toxicity Other Serious 39 Female 7/11/2008 Other Health Professional United Kingdom
Primary
Secondary
Therapeutic Agent Toxicity Other Serious Male 7/11/2008 Other Health Professional United Kingdom
Primary
Secondary
Therapeutic Agent Toxicity Other Serious Male 7/11/2008 United Kingdom
Primary
Secondary
Toxic Encephalopathy Hospitalization Male 7/4/2008 United Kingdom
Primary
Secondary
White Blood Cell Count Increased Life Threatening 53 Male 7/17/2008 Australia
Primary
Secondary
Concomitant
White Blood Cell Count Increased Life Threatening 53 Male 7/25/2008 Australia
Primary
Secondary
Concomitant
Urinoma Hospitalization 39 Female 7/30/2008 United Kingdom
Primary
Secondary

Drug Data